ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Cancer Accounts for 23% of U.S. Deaths, American Cancer Society Says.

January 21, 2005

FASEB Delivers Its Recommendations For Federal Research Funding in 2013

February 3, 2012

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003

Elderly Men Say Physicians Are Recommending PSA Tests

December 26, 2003

Senate Voices Discontent With NIH, NCI Budget; Gorton Presses Raub On Cancer’s ‘Low Priority’

March 22, 1991

Obey Raps Reagan Administration For Blocking Report On Formaldehyde Danger

March 27, 1981